Skip to main content

Table 3 Pooled fixed effects (correlations) by year of publication, study design, platform, time interval between administrations, age, sample size and publication type for the 435 available correlations and 61 correlations averaged over each study/platform

From: Equivalence of electronic and paper administration of patient-reported outcome measures: a systematic review and meta-analysis of studies conducted between 2007 and 2013

Study characteristic

N = 61

N = 435

N

Correlation (95 % CI)

N

Correlation (95 % CI)

Year of publication

 2007

12

0.854 (0.839–0.867)

128

0.835 (0.830–0.840)

 2008–2010

17

0.879 (0.868–0.890)

98

0.873 (0.869–0.877)

 2011

15

0.876 (0.864–0.888)

128

0.891 (0.886–0.896)

 2012–2013

17

0.895 (0.886–0.904)

81

0.877 (0.873–0.882)

  

p < 0.001

 

p < 0.001

 2007–2010

29

0.868 (0.859–0.876)

226

0.852 (0.849–0.856)

 2011–2013

32

0.888 (0.881–0.895)

209

0.883 (0.880–0.886)

  

p < 0.001

 

p < 0.001

Study design

 Randomized cross over

44

0.884 (0.878–0.889)

287

0.876 (0.874–0.879)

 Non–randomised cross over

3

0.825 (0.775–0.865)

22

0.825 (0.807–0.841)

 Within–patient study

14

0.858 (0.842–0.873)

126

0.828 (0.822–0.833)

  

p < 0.001

 

p < 0.001

 Randomiseda

45

0.884 (0.878–0.889)

293

0.876 (0.874–0.879)

 Not randomised

16

0.853 (0.837–0.867)

142

0.826 (0.820–0.831)

  

p < 0.001

 

p < 0.001

Platform

 Paper vs IVRS

8

0.845 (0.824–0.864)

54

0.844 (0.836–0.850)

 Paper vs PDA

10

0.851 (0.830–0.859)

69

0.851 (0.844–0.859)

 Paper vs Web/PC

34

0.886 (0.879–0.893)

197

0.863 (0.859–0.866)

 Paper vs Tablet/touch screen

7

0.890 (0.876–0.902)

91

0.877 (0.872–0.881)

 Web/PC vs IVRS

1

0.880 (0.841–0.910)

2

0.917 (0.898–0.932)

 Tablet/touch vs Web/PC

1

0.899 (0.837–0.938)

22

0.917 (0.908–0.926)

  

p < 0.001

 

p < 0.001

Time interval

 0 (<1 day)

22

0.901 (0.892–0.909)

223

0.890 (0.887–0.893)

 1 (1–5 days)

13

0.891 (0.882–0.900)

83

0.877 (0.874–0.881)

 2 (6–14 days)

19

0.852 (0.840–0.864)

91

0.813 (0.805–0.819)

 3 (15+ days)

7

0.820 (0.791–0.845)

38

0.779 (0.767–0.791)

  

p < 0.001

 

p < 0.001

 0 (<1 day)

22

0.901 (0.892–0.909)

223

0.890 (0.887–0.893)

 1 (1–9 days)

26

0.881 (0.873–0.888)

148

0.862 (0.859–0.866)

 2 (10+ days)

13

0.819 (0.799–0.837)

64

0.790 (0.781–0.798)

  

p < 0.001

 

p < 0.001

Mean age of participantsb

 <28 years

12

0.794 (0.772–0.814)

80

0.789 (0.781–0.796)

 28–46.9 years

15

0.896 (0.888–0.904)

98

0.875 (0.871–0.878)

 47–55.9 years

12

0.889 (0.878–0.900)

103

0.877 (0.873–0.881)

 56+ years

18

0.880 (0.868–0.891)

141

0.886 (0.881–0.891)

  

p < 0.001

 

p < 0.001

Sample size

 ≤56

20

0.881 (0.863–0.896)

126

0.885 (0.878–0.891)

 57–116

21

0.881 (0.870–0.891)

184

0.866 (0.862–0.870)

 >116

20

0.887 (0.870–0.884)

125

0.861 (0.858–0.864)

  

p = 0.817

 

p < 0.001

Publication type

 Abstract/poster

10

0.898 (0.889–0.906)

26

0.905 (0.900–0.910)

 Full text publication

51

0.870 (0.864–0.877)

409

0.859 (0.856–0.861)

  

p < 0.001

 

p < 0.001

  1. aPatients in 1 within–patient study [20] were randomly assigned to complete 2 versions of 1 of 4 instruments
  2. bFour studies [7, 23, 48, 71] did not provide information on the age of their participants